Stay updated on Neoadjuvant Anti-PD1 in Head & Neck Melanoma Clinical Trial
Sign up to get notified when there's something new on the Neoadjuvant Anti-PD1 in Head & Neck Melanoma Clinical Trial page.

Latest updates to the Neoadjuvant Anti-PD1 in Head & Neck Melanoma Clinical Trial page
- Check6 days agoChange Detected- Page revision updated from v3.4.2 to v3.4.3. No user-facing content or functionality was changed.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded a new site revision notice 'Revision: v3.4.2' and removed previous notices, including the 'lapse in government funding' message and 'Revision: v3.4.1'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedAdded a site-wide notice about government funding lapse and NIH Clinical Center operations, and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check49 days agoChange DetectedAdded a glossary toggle. Updated page metadata to show 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0' and removed the previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.2%

- Check56 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4 on the page. The update does not affect study details, eligibility criteria, or results.SummaryDifference0.0%

- Check84 days agoChange DetectedAdded a 'Revision: v3.3.3' note and removed the 'HHS Vulnerability Disclosure' link along with the older 'Revision: v3.3.2' reference. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Neoadjuvant Anti-PD1 in Head & Neck Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neoadjuvant Anti-PD1 in Head & Neck Melanoma Clinical Trial page.